Brief: Denali Therapeutics Reports First Quarter 2023 Financial Results And Business Highlights
08/05/2023 22:28
Denali Therapeutics Inc DNLI.O :
* DENALI THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND BUSINESS HIGHLIGHTS
* QTRLY LOSS PER SHARE $0.80
* Q1 EARNINGS PER SHARE VIEW $-0.70 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9RHw8V
Further company coverage: DNLI.O
Recent news on Denali Therapeutics
See all newsDenali Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Denali Therapeutics Q2 net loss widens as AVLAYAH launch costs rise
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed
U.S. STOCKS ON THE MOVE-Sweetgreen, Dell Technologies, Peloton Interactive
U.S. STOCKS ON THE MOVE-IMAX, Novo Nordisk, PC makers